Company Profile

Vasowatch LLC
Profile last edited on: 7/20/2023      CAGE: 94ZH6      UEI: YA4RTNCNA6Z5

Business Identifier: Improving maternal health and outcomes: deploying decision support technology
Year Founded
2021
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3401 Grays Ferry Avenue
Philadelphia, PA 19146
   (814) 881-8045
   N/A
   www.vasowatch.com
Location: Single
Congr. District: 03
County: Philadelphia

Public Profile

With the primary focus by Vasowatch personnel being to tackle improvement of risk prediction for postpartum hemorrhage (PPH) - the latter is defined by the firm's management as the leading cause of death in labor and delivery and up to six days postpartum. It is estimated that PPH occurs in 5% of all births, 40% assessed as "low risk" per the current expert-based risk assessment surveys administered upon admission.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $244,683
Project Title: Momitor: Wearable Technology for Early Detection of Postpartum Hemorrhage

Key People / Management

  Christine Rohan -- CEO

Company News

There are no news available.